[Relevance of genetic polymorphisms in voriconazole neurotoxicity: case report in a pediatric patient]. [PDF]
Martín-Roldán A +3 more
europepmc +1 more source
Identification of SnRNA U6 as an endogenous reference gene for normalization of MiRNA expression data in COVID-19 patients. [PDF]
de Santana Silva ÍTS +10 more
europepmc +1 more source
Farmacogenómica y su impacto en la respuesta individual de los medicamentos cardiovasculares [PDF]
Introduction: the discovery of the human genome set the tone for the development of pharmacogenomics, which has given promising results that invite the prescription of individualized medicine with the aim of optimizing the response to treatment and ...
Boris Miclin, Carlos David +2 more
core +1 more source
Genómica y proteómica: Un paso más
El desarrollo de la genómica y proteómica descansan sobre los descubrimientos fundamentales que constituyen hitos históricos sin los cuales no hubiera sido posible el hallazgo de nuevos paradigmas, teorías, tecnología, que han cambiado drásticamente el ...
Franklin Aldecoa Bedoya +1 more
doaj
Influence of SARS-CoV-2 variants on COVID-19 epidemiological and clinical profiles: a comparative analysis of two waves of cases. [PDF]
Dos Santos PR +14 more
europepmc +1 more source
Curso electivo sobre variabilidad genética y respuesta a fármacos para estudiantes de medicina [PDF]
Introduction: individual genetic variability significantly influences drug response, impacting treatment efficacy and safety. Objective: to design an elective course for medical students, with the purpose of providing them with a solid foundation on ...
Legrá-Pelier, Déborah Ysabel +4 more
core
The Impact of the COVID-19 Pandemic on the Clinical and Epidemiological Profile of Severe Acute Respiratory Infection in Bahia, Brazil: A Comparative Analysis of Pre- and Post-Pandemic Trends. [PDF]
Magalhães Bronze K +8 more
europepmc +1 more source
[Pharmacogenomics of sevoflurane: role in emergence delirium]. [PDF]
Nair A.
europepmc +1 more source
Pharmacogenetics and Molecular Ancestry of <i>SLC22A1</i>, <i>SLC22A2</i>, <i>SLC22A3</i>, <i>ABCB1</i>, <i>CYP2C8</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Ecuadorian Subjects with Type 2 Diabetes Mellitus. [PDF]
Ortega-Ayala A +8 more
europepmc +1 more source
Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity. [PDF]
Stewart S +12 more
europepmc +1 more source

